MP NHM CHO-2024 (Shif…: In type II hypersensitivity reactions, which mechanism leads to tissue damage?

MP NHM CHO-2024 (Shift-2)

Pathology & Genetics

Easy

Appeared in: MP NHM CHO-2024 (Shift-2)

Explanation

Type II hypersensitivity, also known as cytotoxic hypersensitivity, is defined by the action of IgG or IgM antibodies directed against antigens on cell surfaces or in the extracellular matrix.
This antibody binding marks the cell for destruction, making 'antibody-mediated cell destruction' the primary and most comprehensive description of the overall process.
This process leads to tissue damage through several specific pathways, including complement activation, opsonization, and phagocytosis.

Option B: This is a specific pathway within the broader mechanism of antibody-mediated cell destruction, not the overarching process itself. Complement is activated after antibodies bind to the target cell.
Option C: Similar to complement activation, this is a sub-mechanism. Antibodies act as opsonins to facilitate phagocytosis, but this is just one way antibody-mediated destruction occurs.
Option D: This is the defining pathogenic mechanism of Type III hypersensitivity, where circulating antigen-antibody complexes deposit in tissues and cause inflammation.

Visual 1: Diagram: Illustrating the three main mechanisms of Type II hypersensitivity: 1) Complement-mediated lysis, 2) Opsonization and phagocytosis, and 3) Antibody-dependent cellular cytotoxicity (ADCC).
Visual 2: Table: Comparing the four types of hypersensitivity reactions (Gell and Coombs classification), highlighting the key mediator and mechanism for each.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Mechanism of Type II (Cytotoxic) Hypersensitivity as background academic context rather than a clinical decision trigger.
Understanding this mechanism is crucial for nurses to recognize and manage conditions like hemolytic transfusion reactions, where a patient's antibodies attack transfused red blood cells, leading to fever, chills, and potential kidney failure.
This knowledge is also vital in obstetrics for managing Rh incompatibility (hemolytic disease of the newborn), where maternal IgG antibodies cross the placenta and destroy fetal red blood cells.
What if? If a patient developed a rash, arthritis, and glomerulonephritis one week after receiving a foreign serum, the mechanism would likely be Type III (immune complex deposition), not Type II, due to the systemic deposition of antigen-antibody complexes.

How to Approach the Question

First, identify the core concept from the question stem: the mechanism of Type II hypersensitivity.
Recall the Gell and Coombs classification of the four types of hypersensitivity reactions.
Analyze the options. Recognize that 'Complement activation' and 'Opsonization and phagocytosis' are specific processes that occur during a Type II reaction.
Identify 'Antibody-mediated cell destruction' as the broader, all-encompassing term that defines Type II reactions and includes the other two processes as sub-mechanisms.
Eliminate 'Deposition of immune complexes' as this is the defining mechanism for Type III hypersensitivity.
Conclude that the most accurate and primary mechanism is the one that provides the best overall description, which is antibody-mediated cell destruction.

Concept Tested & Keywords

QSwf-AiJbtELziFNlj1zQE

E6 Pathology-Textbook of PATHOLOGY 9th Edition Harsh Mohan Part 2 (215-514) p. 215-514